● Recruiting

An Open-Label, Single-Arm Exploratory Clinical Study of Everolimus for the Treatment of Vascular Malformations

Condition: Vascular Malformations · Sponsor: Xuanwu Hospital, Beijing

PhasePhase 2

Planned participants10

Who can joinAll sexes, 18 Years to 65 Years

Healthy volunteersNo

About this study

This study is a single-arm exploratory trial conducted by Xuanwu Hospital, Capital Medical University, aiming to evaluate the efficacy and safety of everolimus monotherapy in adult patients with vascular malformations.

This description comes directly from the study's public registry record.

Talk to the study team

Tao Hong, MD · +86-13810000653 · hongtao.edu@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

the Department of Neurosurgery, China International Neuroscience Institute, Xuanwu Hospital, Capital Medical University

Beijing, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07037238